Literature DB >> 3182997

Oral infections and septicemia in immunocompromised patients with hematologic malignancies.

O J Bergmann1.   

Abstract

To estimate the role of oral infections during septicemic episodes in immunocompromised patients with hematologic malignancies, 78 febrile episodes in 46 patients were monitored with daily clinical and microbiological investigations. The 19 septicemic episodes did not differ from the 59 other febrile episodes in the qualitative composition of the aerobic and facultatively anaerobic oral microflora or in the presence of teeth or acute oral infections on day 1. The oral prevalence rates of members of the family Enterobacteriaceae were higher on days 10, 11, and 12 in the febrile episodes with septicemia when compared with those of febrile episodes without septicemia. The prevalence of a probable oral focus in septicemia was 10.5%, and the prevalence of a probable or possible oral origin in septicemia was 31.6%. The results suggest that prevention and elimination of oral infections may reduce the morbidity and perhaps even the mortality in these patients.

Entities:  

Mesh:

Year:  1988        PMID: 3182997      PMCID: PMC266825          DOI: 10.1128/jcm.26.10.2105-2109.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases.

Authors:  C Singer; M H Kaplan; D Armstrong
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

2.  [Septicemia in acute leukemia].

Authors:  J Palmblad
Journal:  Lakartidningen       Date:  1972-09-20

3.  The survival time for different bacteria in various transport media.

Authors:  B Gästrin; L O Kallings; A Marcetic
Journal:  Acta Pathol Microbiol Scand       Date:  1968

4.  Comparative analysis of two blood culture systems (Isolator and a 12-tube system) by cumulative differences in detection power at different times during incubation.

Authors:  M Arpi; J Prag; S S Schrøder; M W Bentzon; W Frederiksen
Journal:  APMIS       Date:  1988-05       Impact factor: 3.205

5.  Mucosal penetrability enhanced by serum-derived antibodies.

Authors:  P Brandtzaeg; K Tolo
Journal:  Nature       Date:  1977-03-17       Impact factor: 49.962

6.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

Authors:  S C Schimpff; V M Young; W H Greene; G D Vermeulen; M R Moody; P H Wiernik
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

Review 7.  Fever and infection in leukemic patients: a study of 494 consecutive patients.

Authors:  G P Bodey; V Rodriguez; H Y Chang
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

8.  Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged.

Authors:  W M Valenti; R G Trudell; D W Bentley
Journal:  N Engl J Med       Date:  1978-05-18       Impact factor: 91.245

9.  Rapid identification of Enterobacteriaceae. II. Use of a beta-glucuronidase detecting agar medium (PGUA agar) for the identification of E. coli in primary cultures of urine samples.

Authors:  M Kilian; P Bülow
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-10

10.  Pneumococcal sepsis in childhood leukemia and lymphoma.

Authors:  J B Allen; L B Weiner
Journal:  Pediatrics       Date:  1981-02       Impact factor: 7.124

View more
  19 in total

1.  Dental treatment intensity in frail older adults in the last year of life.

Authors:  Xi Chen; Hong Chen; Christian Douglas; John S Preisser; Stephen K Shuman
Journal:  J Am Dent Assoc       Date:  2013-11       Impact factor: 3.634

2.  Evaluation of risk factors for oral infection with potential for spread in a 1-year cohort study.

Authors:  Esa Färkkilä; Riina Rautemaa-Richardson; Anniina Färkkilä; Lotta Grönholm; Anneli Lauhio
Journal:  Clin Oral Investig       Date:  2018-06-14       Impact factor: 3.573

3.  Mucositis prevention by improved dental care in acute leukemia patients.

Authors:  Milanko Djuric; Valeria Hillier-Kolarov; Aranka Belic; Ljiljana Jankovic
Journal:  Support Care Cancer       Date:  2005-07-22       Impact factor: 3.603

4.  Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients.

Authors:  E M Ibrahim; F A al-Mulhim
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

5.  Dental caries, gingival health, and oral hygiene of long term survivors of paediatric malignant diseases.

Authors:  F Dens; P Boute; J Otten; F Vinckier; D Declerck
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

6.  Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy.

Authors:  Joel B Epstein; Edmond L Truelove; Kimberly Hanson-Huggins; Lloyd A Mancl; Alice Chen; Oliver W Press; Stephen H Petersdorf; Thomas R Fritsche; Joshua D Epstein
Journal:  Support Care Cancer       Date:  2004-04-24       Impact factor: 3.603

7.  Dental caries in older adults in the last year of life.

Authors:  Xi Chen; Jennifer J Clark; John S Preisser; Supawadee Naorungroj; Stephen K Shuman
Journal:  J Am Geriatr Soc       Date:  2013-07-18       Impact factor: 5.562

8.  Detection of Helicobacter pylori, Enterococcus faecalis, and Pseudomonas aeruginosa in the subgingival biofilm of HIV-infected subjects undergoing HAART with chronic periodontitis.

Authors:  L de Souza Gonçalves; R Souto; A P V Colombo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-07-29       Impact factor: 3.267

9.  Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial.

Authors:  O J Bergmann; S Ellermann-Eriksen; S C Mogensen; J Ellegaard
Journal:  BMJ       Date:  1995-05-06

10.  Dental treatment prior to stem cell transplantation and its influence on the posttransplantation outcome.

Authors:  A B Melkos; G Massenkeil; R Arnold; P A Reichart
Journal:  Clin Oral Investig       Date:  2003-05-24       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.